Literature DB >> 10946432

Random-effects regression analysis of correlated grouped-time survival data.

D Hedeker1, O Siddiqui, F B Hu.   

Abstract

Random-effects regression modelling is proposed for analysis of correlated grouped-time survival data. Two analysis approaches are considered. The first treats survival time as an ordinal outcome, which is either right-censored or not. The second approach treats survival time as a set of dichotomous indicators of whether the event occurred for time periods up to the period of the event or censor. For either approach both proportional hazards and proportional odds versions of the random-effects model are developed, while partial proportional hazards and odds generalizations are described for the latter approach. For estimation, a full-information maximum marginal likelihood solution is implemented using numerical quadrature to integrate over the distribution of multiple random effects. The quadrature solution allows some flexibility in the choice of distributions for the random effects; both normal and rectangular distributions are considered in this article. An analysis of a dataset where students are clustered within schools is used to illustrate features of random-effects analysis of clustered grouped-time survival data.

Mesh:

Year:  2000        PMID: 10946432     DOI: 10.1177/096228020000900206

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  27 in total

1.  Partnerships for the design, conduct, and analysis of effectiveness, and implementation research: experiences of the prevention science and methodology group.

Authors:  C Hendricks Brown; Sheppard G Kellam; Sheila Kaupert; Bengt O Muthén; Wei Wang; Linda K Muthén; Patricia Chamberlain; Craig L PoVey; Rick Cady; Thomas W Valente; Mitsunori Ogihara; Guillermo J Prado; Hilda M Pantin; Carlos G Gallo; José Szapocznik; Sara J Czaja; John W McManus
Journal:  Adm Policy Ment Health       Date:  2012-07

Review 2.  Design and analysis of group-randomized trials: a review of recent methodological developments.

Authors:  David M Murray; Sherri P Varnell; Jonathan L Blitstein
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

3.  Developmental considerations in survival models as applied to substance use research.

Authors:  Kristina M Jackson; Tim Janssen
Journal:  Addict Behav       Date:  2018-11-20       Impact factor: 3.913

4.  Longitudinal course of bipolar I disorder: duration of mood episodes.

Authors:  David A Solomon; Andrew C Leon; William H Coryell; Jean Endicott; Chunshan Li; Jess G Fiedorowicz; Lara Boyken; Martin B Keller
Journal:  Arch Gen Psychiatry       Date:  2010-04

5.  Antidepressants and risks of suicide and suicide attempts: a 27-year observational study.

Authors:  Andrew C Leon; David A Solomon; Chunshan Li; Jess G Fiedorowicz; W H Coryell; Jean Endicott; Martin B Keller
Journal:  J Clin Psychiatry       Date:  2011-05       Impact factor: 4.384

6.  Risk of suicidal behavior with antidepressants in bipolar and unipolar disorders.

Authors:  Andrew C Leon; Jess G Fiedorowicz; David A Solomon; Chunshan Li; William H Coryell; Jean Endicott; Jan Fawcett; Martin B Keller
Journal:  J Clin Psychiatry       Date:  2014-07       Impact factor: 4.384

7.  A multivariate discrete failure time model for the analysis of infant motor development.

Authors:  Brian Neelon; Azza Shoaibi; Sara E Benjamin-Neelon
Journal:  Stat Med       Date:  2018-11-28       Impact factor: 2.373

8.  Do risk factors for suicidal behavior differ by affective disorder polarity?

Authors:  J G Fiedorowicz; A C Leon; M B Keller; D A Solomon; J P Rice; W H Coryell
Journal:  Psychol Med       Date:  2008-07-30       Impact factor: 7.723

9.  Methods for Multilevel Ordinal Data in Prevention Research.

Authors:  Donald Hedeker
Journal:  Prev Sci       Date:  2015-10

10.  Context or composition: what explains variation in SCHIP disenrollment?

Authors:  Julie A Phillips; Jane E Miller; Joel C Cantor; Dorothy Gaboda
Journal:  Health Serv Res       Date:  2004-08       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.